Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 003043.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 26.47 11.71 9.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 5.36 -9.75 -10.30
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.07 14.53 14.23
Cash -4.08 9.42 9.82
Capex 58.13 -0.29 -0.69
Free Cash Flow -128.46 -0.36 -0.16
Revenue 23.46 1.42 1.15
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -3.96 0.34 0.35
Operating Margin 2.55 0.20 0.20
ROA 42.74 0.02 0.01
ROE 39.99 0.02 0.01
ROIC 22.16 0.01 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 003043.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 003043.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 003043.SZ is permitted for members.